SmithKline

Adam sez, Basically SmithKline is saying that [generic drug maker] Apotex can't make Paxil because at a crystalline level, contamination from them making another drug will cause minute amounts of * their* patented drug to be produced as a side effect.

Boing Boing: March 2, 2003 - March 8, 2003 Archives 2003

This analysis shows GlaxoSmithKline (mentioned twice using also the old "SmithKline" name) as the most vulnerable company in terms of its number of products.

WindyBits - Main 2009

Sykes built his reputation in the City by transforming Glaxo into GSK through mergers with Wellcome and SmithKline Beecham.

Sir Richard Sykes: voted out, but not down 2011

By mid-2003, Ms. Eckard was terminated in what the company called a "redundancy" related to the merger of Glaxo Wellcome and SmithKline Beecham PLC a couple of years before.

Whistleblower's Long Journey Peter Loftus 2010

Sykes built his reputation in the City by transforming Glaxo into GSK through mergers with Wellcome and SmithKline Beecham.

Sir Richard Sykes: voted out, but not down 2011

"Thanks to his judgment, charisma and experience he made the integration of GlaxoWellcome and SmithKline Beecham a true success," Mr. Cawthorn said, adding "his operational and financial expertise is respected across the industry."

Actelion Makes Board Move Goran Mijuk 2011

Scientists from Aventis Pasteur, Merck, Wyeth, and SmithKline Beecham, the four pharmaceutical companies that continued to distribute vaccines in the United States, were also in attendance.

The Panic Virus Seth Mnookin 2011

Scientists from Aventis Pasteur, Merck, Wyeth, and SmithKline Beecham, the four pharmaceutical companies that continued to distribute vaccines in the United States, were also in attendance.

The Panic Virus Seth Mnookin 2011

A $125 million investment from Glaxo's predecessor company, SmithKline Beecham, supported the effort.

Gene Work Yields New Treatment For Lupus Ron Winslow 2011

Both Mr. Garnier and Mr. Bertolini have considerable takeover experience–the former at SmithKline Beecham, the latter on the board of U.S. biotech Genzyme.

Actelion Squares Up for a Fight Hester Plumridge 2011